Search for: ""Daubert v. Merrell Dow Pharmaceuticals, Inc." OR "509 U.S. 579"" Results 61 - 80 of 112
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Feb 2013, 7:23 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509, U.S. 579 (1993). [read post]
13 Apr 2007, 8:09 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), and Frye v. [read post]
31 Mar 2016, 8:09 am by Jetta Sandin and Jay Levine
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), nor did Tyson offer a rebuttal expert witness. [read post]
18 Jan 2007, 10:48 am
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [read post]
8 May 2020, 3:47 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993). [2]  Frye v. [read post]
24 Dec 2012, 9:58 am by Schachtman
Merrell Dow Pharmaceuticals Inc., 509 U.S. 579 (1993), a case that has been superseded by subsequent cases and a revision to the operative statute, Rule 702. [read post]
11 Mar 2013, 8:30 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, has solidified that trend. [read post]
3 Jan 2015, 3:47 pm by Robert Kreisman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993) and granted BNSF’s motion for summary judgment. [read post]
13 May 2020, 2:03 am by Schachtman
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579, 592 n.10 (1993). [3]  Id., citing Bourjaily v. [read post]